8-K: Avinger Stockholders Approve Key Proposals for Convertible Preferred Stock Issuance

Avinger, Inc. stockholders approved the issuance of common stock upon conversion of Series F and G Preferred Stock at a special meeting on May 22, 2024.

Summary

• Avinger, Inc. held a Special Meeting of Stockholders on May 22, 2024.
• Stockholders voted on three proposals related to the issuance of common stock upon conversion of Series F and G Convertible Preferred Stock.
• Proposal 1, approving the issuance of over 19.9% of outstanding common stock upon conversion of Series F Preferred Stock, was approved with 716,164 votes for, 94,610 against, and 394 abstentions.
• Proposal 2, approving the issuance of Series G Preferred Stock and over 19.9% of common stock upon conversion at less than the minimum price under Nasdaq rules, was approved with 703,493 votes for, 107,306 against, and 369 abstentions.
• Proposal 3, to adjourn the meeting if necessary to solicit more votes, was also approved with 704,561 votes for, 94,190 against, and 12,147 abstentions, but was not needed due to the approval of the first two proposals.
• No other matters were considered or voted upon at the Special Meeting.

Sentiment

Score: 7

Explanation: The document indicates positive progress for Avinger as it secures shareholder approval for key financial actions, but the potential dilution and below-market issuance raise some concerns.

Positives

• The approval of the proposals allows Avinger to proceed with the planned issuance of common stock upon conversion of Series F and G Preferred Stock.
• The high number of votes in favor of the proposals indicates strong stockholder support for the company's plans.

Risks

• The issuance of a significant amount of new common stock could potentially dilute existing shareholders' ownership.
• The issuance of stock at less than the minimum price under Nasdaq rules could raise concerns about the company's valuation.

Industry Context

This announcement is specific to Avinger's capital structure and does not directly relate to broader industry trends, but it does show the company is taking steps to secure funding.

Comparison to Industry Standards

• The approval of these proposals is a necessary step for Avinger to raise capital, which is common for companies in the medical device industry, especially those in the development or commercialization phase.
• Many companies in the medical device sector use convertible preferred stock as a financing mechanism, but the specific terms and conditions vary widely.
• The need to seek shareholder approval for issuing more than 19.9% of common stock is a standard requirement under Nasdaq rules, which is similar to other listed companies.

Stakeholder Impact

• Shareholders will be impacted by the potential dilution of their ownership due to the issuance of new common stock.
• The company's ability to raise capital through these issuances could positively impact its long-term prospects.

Next Steps

• Avinger will proceed with the issuance of common stock upon conversion of Series F and G Preferred Stock.

Key Dates

Keywords

Avinger, Stockholders, Series F Preferred Stock, Series G Preferred Stock, Convertible Preferred Stock, Common Stock, Nasdaq, Issuance, Special Meeting, Voting